barcelona . spain - European Association for the Study of the Liver
barcelona . spain - European Association for the Study of the Liver
barcelona . spain - European Association for the Study of the Liver
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
BARCELONA . SPAIN<br />
74 POSTGRADUATE COURSE SYLLABUS ALCOHOLIC LIVER DISEASE 75<br />
APRIL 18 - 19/2012 THE INTERNATIONAL LIVER CONGRESS TM 2012<br />
REFERENCES<br />
Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, et al. Transient<br />
elastography as a screening tool <strong>for</strong> liver fibrosis and cirrhosis in a community-based population<br />
aged over 45 years. GUT 2011;60:977-984.<br />
Hock B SM, Domke I, Grunert VP, Wuertemberger M, Schiemann U, Horster S, Limmer<br />
C, Stecker G, Soyka M. Validity <strong>of</strong> carbohydrate-deficient transferrin (%CDT), gammaglutamyltransferase<br />
(gamma-GT) and mean corpuscular erythrocyte volume (MCV) as<br />
biomarkers <strong>for</strong> chronic alcohol abuse: a study in patients with alcohol dependence and liver<br />
disorders <strong>of</strong> non-alcoholic and alcoholic origin. Addiction 2005;100:1477-1486.<br />
Bell H TC, Try K, Haug E. Carbohydrate-deficient transferrin and o<strong>the</strong>r markers <strong>of</strong> high alcohol<br />
consumption: a study <strong>of</strong> 502 patients admitted consecutively to a medical department. Alcohol<br />
Clin Exp Res 1994;18:1103-1108.<br />
Seitz HK. Additive effects <strong>of</strong> moderate drinking and obesity on serum gamma-glutamyl<br />
transferase. Am J Clin Nutr 2006;83:1252-1253.<br />
Ferenci P, Dragosics B, Pesendorfer FX, Schubert H. [Gamma-glutamyl-transpeptidase in<br />
alcoholic liver diseases]. Acta Med Austriaca 1976;3:50-54.<br />
Cohen JA, Kaplan MM. The SGOT/SGPT ratio--an indicator <strong>of</strong> alcoholic liver disease. Dig Dis Sci<br />
1979;24:835-838.<br />
Helander A, Tabak<strong>of</strong>f B. Biochemical markers <strong>of</strong> alcohol use and abuse: experiences from<br />
<strong>the</strong> Pilot <strong>Study</strong> <strong>of</strong> <strong>the</strong> WHO/ISBRA Collaborative Project on state and trait markers <strong>of</strong> alcohol.<br />
International Society <strong>for</strong> Biomedical Research on Alcoholism. Alcohol Alcohol 1997;32:133-144.<br />
Zoli M, Cordiani MR, Marchesini G, Iervese T, Labate AM, Bonazzi C, et al. Prognostic indicators<br />
in compensated cirrhosis. Am J Gastroenterol 1991;86:1508-1513.<br />
Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter (CAP):<br />
A novel tool <strong>for</strong> <strong>the</strong> non-invasive evaluation <strong>of</strong> steatosis using Fibroscan((R)). Clin Res Hepatol<br />
Gastroenterol 2011.<br />
d’Assignies G RM, Khiat A, Lepanto L, Chagnon M, Kauffmann C, et al. Noninvasive quantitation<br />
<strong>of</strong> human liver steatosis using magnetic resonance and bioassay methods Eur Radiol 2009;19<br />
2033-2040.<br />
Mancini M PA, Annuzzi G, Liuzzi R, Giacco R, Medagli C, Cremone M, Clemente G, Maurea S,<br />
Riccardi G, Rivellese AA, Salvatore M. Sonographic hepatic-renal ratio as indicator <strong>of</strong> hepatic<br />
steatosis: comparison with (1)H magnetic resonance spectroscopy. Metabolism<br />
2009;58:1724-1730.<br />
Ratziu V BS, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based<br />
on <strong>the</strong> EASL 2009 special conference. J Hepatol 2010;53:372-384.<br />
Mueller S, Sandrin L. <strong>Liver</strong> stiffness: a novel parameter <strong>for</strong> <strong>the</strong> diagnosis <strong>of</strong> liver disease Hepatic<br />
Medicine: Evidence and Research 2010;2:49-67.<br />
Castera L. Non-invasive assessment <strong>of</strong> liver fibrosis in chronic hepatitis C. Hepatol Int 2011;<br />
5:625-634.<br />
Naveau S GG, Asnacios A, Agostini H, Abella A, Barri-Ova N, Dauvois B, Prevot S, Ngo Y,<br />
Munteanu M, Balian A, Njike-Nakseu M, Perlemuter G, Poynard T. Diagnostic and prognostic<br />
values <strong>of</strong> noninvasive biomarkers <strong>of</strong> fibrosis in patients with alcoholic liver disease.<br />
Hepatology 2009;49:97-105.<br />
Nguyen-Khac E, Chatelain D, Tramier B, Decrombecque C, Robert B, Joly JP, et al. Assessment<br />
<strong>of</strong> asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with<br />
seven non-invasive laboratory tests. Aliment Pharmacol Ther 2008;28:1188-1198.<br />
Rosenberg WM VM, Thiel R. Becka M, Burt A, Schuppan D, Hubscher S, Roskams<br />
T, Pinzani M, Arthur MJ. Serum markers detect <strong>the</strong> presence <strong>of</strong> liver fibrosis: a cohort study.<br />
Gastroenterology 2004;127:1704-1713.<br />
Lieber CS WD, Morgan TR, Paronetto F. Aspartate aminotransferase to platelet ratio index<br />
in patients with alcoholic liver fibrosis. Am J Gastroenterol 2006;101:1500-1508.<br />
Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers<br />
<strong>of</strong> liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357:<br />
1069-1075.<br />
Naveau S, Raynard B, Ratziu V, Abella A, Imbert-Bismut F, Messous D, et al. Biomarkers <strong>for</strong><br />
<strong>the</strong> prediction <strong>of</strong> liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol<br />
Hepatol 2005;3:167-174.<br />
Cales P OF, Michalak S, Hubert-Fouchard I, Rousselet MC, Konate A, Gallois Y, Ternisien C,<br />
Chevailler A, Lunel F. A novel panel <strong>of</strong> blood markers to assess <strong>the</strong> degree <strong>of</strong> liver fibrosis.<br />
Hepatology 2005;42:1373-1181.<br />
Parkes J RP, Harris S, Day C, Mutimer D, Collier J, Lombard M, Alexander G, Ramage J,<br />
Dusheiko G, Wheatley M, Gough C, Burt A, Rosenberg W. Enhanced liver fibrosis test can<br />
predict clinical outcomes in patients with chronic liver disease. GUT 2010;59:1245-1251.<br />
Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography:<br />
a new noninvasive method <strong>for</strong> assessment <strong>of</strong> hepatic fibrosis. Ultrasound Med Biol<br />
2003;29:1705-1713.<br />
Castera L PM. Biopsy and non-invasive methods <strong>for</strong> <strong>the</strong> diagnosis <strong>of</strong> liver fibrosis: does it take<br />
two to tango GUT 2010;59:861-866.<br />
Boursier J, Konate A, Guilluy M, Gorea G, Sawadogo A, Quemener E, et al. Learning curve and<br />
interobserver reproducibility evaluation <strong>of</strong> liver stiffness measurement by transient elastography.<br />
Eur J Gastroenterol Hepatol 2008;20:693-701.<br />
Kazemi F, Kettaneh A, N’Kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, et al. <strong>Liver</strong> stiffness<br />
measurement selects patients with cirrhosis at risk <strong>of</strong> bearing large oesophageal varices. J<br />
Hepatol 2006;45:230-235.<br />
Castera L, Bail BL, Roudot-Thoraval F, Bernard PH, Foucher J, Merrouche W, et al. Early<br />
detection in routine clinical practice <strong>of</strong> cirrhosis and oesophageal varices in chronic hepatitis C:<br />
Comparison <strong>of</strong> transient elastography (FibroScan) with standard laboratory tests and noninvasive<br />
scores. J Hepatol 2009;50:59-68.<br />
Janssens F, de Suray N, Piessevaux H, Horsmans Y, de Timary P, Starkel P. Can Transient<br />
Elastography Replace <strong>Liver</strong> Histology <strong>for</strong> Determination <strong>of</strong> Advanced Fibrosis in Alcoholic<br />
Patients: A Real-life <strong>Study</strong>. J Clin Gastroenterol.<br />
Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, et al. Increased liver<br />
stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J<br />
Gastroenterol 2010;16:966-972.<br />
Nahon P, Kettaneh A, Tengher-Barna I, Ziol M, de Ledinghen V, Douvin C, et al. Assessment<br />
<strong>of</strong> liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol<br />
2008;49:1062-1068.<br />
Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, et al. Acute viral hepatitis increases liver<br />
stiffness values measured by transient elastography. Hepatology 2008;47:380-384.<br />
Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable <strong>for</strong> detection <strong>of</strong><br />
cirrhosis in patients with acute liver damage. Hepatology 2008;47:592-595.<br />
Lanzi A, Gianstefani A, Mirarchi MG, Pini P, Conti F, Bolondi L. <strong>Liver</strong> AL amyloidosis as a possible<br />
cause <strong>of</strong> high liver stiffness values. Eur J Gastroenterol Hepatol 2009.<br />
Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, Mehrabi A, et al. <strong>Liver</strong> stiffness is directly<br />
influenced by central venous pressure. J Hepatol 2010;52:206-210.<br />
Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Buchler MW, et al. Extrahepatic<br />
cholestasis increases liver stiffness (FibroScan) irrespective <strong>of</strong> fibrosis. Hepatology 2008;48:<br />
1718-1723.<br />
Gelsi E, Dainese R, Truchi R, Marine-Barjoan E, Anty R, Autuori M, et al. Effect <strong>of</strong> detoxification<br />
on liver stiffness assessed by fibroscan((R)) in alcoholic patients. Alcohol Clin Exp<br />
Res 2011;35:566-570.